课题基金 / 基金详情

Development of new therapy for hormone independent prostate cancer.

Development of new therapy for hormone independent prostate cancer.
开发激素非依赖性前列腺癌的新疗法。
批准号:
15591689
负责人:
USUI Tsuguru
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

USUI Tsuguru的其他基金

相似基金

相关文献

中文摘要
翻译
本实验研究了FGFR 2 IIIb在激素非依赖性前列腺癌细胞增殖和分化中的作用,并研究了FGFR 2 IIIb转染细胞在放疗和抗癌药物联合治疗中的作用。1)FGFR 2 IIIb转染PC-3细胞的建立:FGFR 2 IIIb转染PC-3细胞的生长速度明显低于对照细胞。PC-3 FGFR 2 IIIb来源的肿瘤的生长速率显著低于对照。PC-3 FGFR 2 IIIb细胞从PC-3 neo细胞形态上改变。免疫细胞化学分析显示,对照组的pancytokeratin和lactoferin染色呈弱阳性,而PC-3 FGFR 2 IIIb细胞的pancytokeratin和lactoferin免疫染色呈强阳性。2)FGFR 2 IIIb的信号转导:FRS 2在FGF-1刺激的PC-3 neo和PC-3 FGFR 2 IIIb细胞中均被鉴定为酪氨酸磷酸化蛋白。FRS 2在PC-3 FGFR 2 IIIb中的信号强度明显强于对照组。在FGF-7的刺激下,FRS 2在PC-3 v细胞中被强烈激活,但在PC-3 neo细胞中没有。在用FGF-1和FGF-7刺激时,在PC-3 FGFR 2 IIIb细胞中检测到p44/42 MAP激酶的磷酸化,但在PC-3 neo细胞中未检测到。3)放射和抗癌剂与FGFR 2 IIIb的协同作用4和8戈伊的放射处理分别使PC 3-IIIb细胞中的集落数显著减少87.7%和99.6%。携带空载体的Mock细胞中的集落数分别减少了69.4%和95.2%。第3天,不含多西他赛的PC-IIIb的平均细胞活力为0.34,PC 3-IIIb 1 +0.01μM多西他赛的平均细胞活力为0.24,PC 3-IIIb + 0.1μM多西他赛的平均细胞活力为0.20。组间差异具有统计学显著性(p<0.0001)。
英文摘要
The role of FGFR2IIIb in cell proliferation anddifferentiation were studied in hormone independentprostate cancer, and usefulness of combination therapyusing radiation and anticancer agent were also studied in the FGFR2IIIb transfected cell.1)Establishment of FGFR2IIIb transfected PC-3 cell :The growth rate of PC-3 FGFR2IIIb transfected cells was significantly slower than that of the control cells. The growth rate of the PC-3 FGFR2IIIb derived tumors was significantly slower than that of the control. PC-3 FGFR2IIIb cells were morphologically changed from PC-3 neo cells. Immunocytochemical analysis revealed a weak pancytokeratin and lactoferrin-positive staining of the control, whereas PC-3 FGFR2IIIb cells showed strong positive pancytokeratin and lactoferin immunostaining. In the apoptosis assay, most of PC-3 FGFR2IIIb cells were stained with the APOPercentage-dye.2)Signal transduction of FGFR2IIIb :FRS2 was identified as a tyrosine-phosphorylated protein in both PC-3 neo and PC-3 FGFR2IIIb cells stimulated with FGF-1. The signal intensity of FRS2 in PC-3 FGFR2IIIb was much stronger than that of the control. On the stimulation with FGF-7, FRS2 was strongly activated in PC-3 v cells but not in PC-3 neo cells. On stimulation with FGF-1 and FGF-7, the phosphorylation of p44/42 MAP kinase was detected in PC-3 FGFR2IIIb cells, but not in PC-3 neo cells.3)Synergistic effects of radiation and an anticancer agent with the FGFR2IIIbFour and 8 Gy of radiation treatment dramatically decreased the number of colonies in PC3-IIIb cells by 87.7 % and 99.6 %, respectively. The number of colonies in Mock cells bearing an empty vector was reduced by 69.4% and 95.2%, respectively. The mean cell viability on day 3 was 0.34 for PC-IIIb without docetaxel, 0.24 for PC3-IIIb1+0.01μM docetaxel, and 0.20 for PC3-IIIb + 0.1μM of docetaxel. The difference between the groups was statistically significant (p<0.0001).
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
IGFBP-rP1の発現回復によるヒト前立腺癌細胞の放射線感受性
通过恢复 IGFBP-rP1 表达来提高人前列腺癌细胞的放射敏感性
DOI: --
发表时间: 2004
期刊: 日本泌尿器科学会雑誌 95
影响因子: --
作者: [Kubo, N., Hiroaki Yasumoto, Mituhiro Seki, 望月英樹, 石 光弘]
通讯作者: 石 光弘
Tumor Induction by Azoxymethane (AOM) and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in F344 Rat Gastric Mucosa Featuring Intestinal Metaplasia Caused by X-irradiation.
氧化偶氮甲烷 (AOM) 和 2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶 (PhIP) 在 F344 大鼠胃粘膜中诱导肿瘤,其特点是 X 射线照射引起的肠化生。
DOI: --
发表时间:
期刊: J.Exp.Clin.Cancer Res. (in press)
影响因子: --
作者: [Kashiwabara, S.]
通讯作者: S.
DOI: --
发表时间: 2005
期刊: Int.J.Mol.Med 15・3
影响因子: --
作者: [Kubo, N.]
通讯作者: N.
Tumor Induction by Azoxymethane(AOM)and 2-Amino-1-methyl-6-phenylmidazo[4,5-b]pyridine (PhP) in F344 Rat Gastric Mucosa Featuring intestinal Metaplasia Caused by X-irradiation.
氧化偶氮甲烷 (AOM) 和 2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶 (PhP) 在 F344 大鼠胃粘膜中诱导肿瘤,其特点是 X 射线照射引起的肠化生。
DOI: --
发表时间:
期刊: J.Exp.Clin.Cancer Res. (In press)
影响因子: --
作者: [Kashiwabara, S.]
通讯作者: S.
共 17 条
    Clinical application and functional analysis of the cofactor of androgen receptor in prostate cancer
    • 批准号:
      18591755
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.48万
    • 财政年份:
      2006
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    Expression & localization of IGF system in human relapsed prostatic carcinoma
    • 批准号:
      11671558
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1999
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    Experimental chemotherapy and radiotherapy for metastatic mouse bladder cancer
    • 批准号:
      03670754
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1991
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    海外基金